Drug
Psilocybin therapy
Psilocybin therapy is a pharmaceutical drug with 5 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
2(40%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
1
20%
Ph phase_2
4
80%
Phase Distribution
0
Early Stage
4
Mid Stage
0
Late Stage
Phase Distribution5 total trials
Phase 2Efficacy & side effects
4(80.0%)
N/ANon-phased studies
1(20.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
5
all time
Status Distribution
Active(3)
Completed(2)
Detailed Status
Completed2
Active, not recruiting1
Not yet recruiting1
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
2
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 24 (80.0%)
N/A1 (20.0%)
Trials by Status
active_not_recruiting120%
completed240%
not_yet_recruiting120%
recruiting120%
Recent Activity
2 active trials
Showing 5 of 5
recruitingphase_2
Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment Disorder
NCT07072728
completednot_applicable
Psilocybin in Alcohol Use Disorder With Comorbid Depression
NCT06235411
not_yet_recruitingphase_2
Psilocybin Therapy for Psychological Distress in Palliative Patients
NCT06782724
completedphase_2
Psilocybin Therapy for Depression and Anxiety in Parkinson's Disease
NCT04932434
active_not_recruitingphase_2
Psilocybin Therapy for Depression in Bipolar II Disorder
NCT05065294
Clinical Trials (5)
Showing 5 of 5 trials
NCT07072728Phase 2
Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment Disorder
NCT06235411Not Applicable
Psilocybin in Alcohol Use Disorder With Comorbid Depression
NCT06782724Phase 2
Psilocybin Therapy for Psychological Distress in Palliative Patients
NCT04932434Phase 2
Psilocybin Therapy for Depression and Anxiety in Parkinson's Disease
NCT05065294Phase 2
Psilocybin Therapy for Depression in Bipolar II Disorder
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5